Die Hereditäre Hämorrhagische Teleangiektasie (Morbus Osler-Rendu-Weber) und ihre Manifestation an der Leber

Zusammenfassung

Der M. Osler (Hereditäre Hämorrhagische Teleangiektasie, HHT) ist eine autosomal-dominant vererbte Erkrankung, die mit vielgestaltigen Gefäßfehlbildungen einhergeht. Die genetische Ursache dieser Erkrankung liegt in unterschiedlichen Defekten von Bindungsproteinen (Endoglin, Activin Receptor-like Kinase 1), die Anteile des Rezeptors für Transforming Growth Factor β darstellen. Von den Gefäßfehlbildungen können auch der Gastrointestinaltrakt und insbesondere die Leber betroffen sein. Der Genlokus für die hepatische Manifestation des M. Osler ist bisher nicht bekannt.

Die Gefäßmalformationen führen zu verschiedenen Shuntformen im Bereich der Leber und können im Erwachsenenalter zu unterschiedlichen Komplikationen wie Herzinsuffizienz, Pfortaderhochdruck und hepatischer Enzephalopathie führen. Als Screeningverfahren zur Frage einer Leberbeteiligung bei Patienten mit M. Osler ist die Farb-Doppler-Sonographie Methode der Wahl. In seltenen Fällen sind die o. g. Komplikationen der Leberbeteiligung konservativ nicht befriedigend zu behandeln. Für diese Patienten stehen interventionelle (Embolisation) und operative (Ligatur der Art. hepatica, Lebertransplantation) Therapieverfahren zur Verfügung. Da der Stellenwert der einzelnen Therapieverfahren nicht festgelegt ist, sollten diese Patienten an einem Zentrum vorgestellt werden, welches alle Therapieverfahren anbieten kann.

Hepatic involvement in hereditary hemorrhagic telangiectasia

M. Osler (Hereditary Hemorrhagic Telangiectasia, HHT) is an autosomal dominant inherited disease, with various vascular malformations. The genetic cause of this disease lies in different defects of transmembrane proteins (endoglin, activin receptor like-kinase 1) that can be defined as components of the receptor complex for transforming growth factor β (TGF β).

Vascular malformations include the gastrointestinal tract and especially the liver. The location of mutations encoding hepatic involvement of M. Osler still remains unknown.

These vascular malformations may lead to different shunts in the liver and can result to different complications like cardiac-insufficiency, portal hypertension and hepatic encephalopathy in adulthood.

Color Doppler sonography is the method of choice for screening patients with M. Osler - suspected of having hepatic involvement.

As in rare events conservative treatment of complications of hepatic involvement fail, embolization of the hepatic artery as minimal invasive therapy, surgical ligation of the A. hepatica and liver transplantation are possible treatment options. As there are only limited experiences with these therapeutic procedures patients with liver involvement should be treated at a center, where all therapy options are available.

M. Osler - Hereditäre hämorrhagische Teleangiektasie - Leber - Embolisation - Sonographie

M. Osler - Hereditary Hemorrhagic Telangiectasia - Liver - Embolization - Sonography

Literatur

• 1 Guttmacher A E, Marchuk D A, White R IJ. Hereditary hemorrhagic telangiectasia.  N Engl J Med. 1995;  333 918-924
• 2 Shovlin C L, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms.  Thorax. 1999;  54 714-729
• 3 Rhiede U N, Schaefer H E, Klein P J. Störungen des Stofftransportes. Rhiede UN, Schaefer, HE, Wehner H. Allgemeine und spezielle Pathologie 1989: 362
• 4 Snyder L H, Doan C A. Clinical and experimental studies in human inheritance: Is the homozygous form of multiple telangiectasia lethal?.  J Lab Clin Med. 1944;  29 1211-1216
• 5 Muller J -Y, Michailov T, Izrael V, Ernard J. Maladie de Rendu-Osler dans une grande famille saharienne.  Nouv Presse Med. 1978;  7 1723-1725
• 6 Plauchu H, de Chadarevian J P, Bideau A, Robert J M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population.  Am J Med Genet. 1989;  32 291-297
• 7 Gallione C J, Klaus D J, Yeh E Y. et al . Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.  Hum Mutat. 1998;  11 286-294
• 8 McAllister K A, Grogg K M, Johnson D W. et al . Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.  Nat Genet. 1994;  8 345-351
• 9 Haitjema T, Westermann C J, Overtoom T T. et al . Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications, and treatment.  Arch Intern Med. 1996;  156 714-719
• 10 Vincent P, Plauchu H, Hazan J. et al . A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q (published erratum appears in Hum Mol Genet 1995;4:1243).  Hum Mol Genet. 1995;  4 945-949
• 11 Johnson D W, Berg J N, Baldwin M A. et al . Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.  Nat Genet. 1996;  13 189-195
• 12 Nikolopoulos N, Xynos E, Vassilakis J S. Familial occurrence of hyperdynamic circulation status due to intrahepatic fistulae in hereditary hemorrhagic telangiectasia.  Hepatogastroenterology. 1988;  35 167-168
• 13 Piantanida M, Buscarini E, Dellavecchia C. et al . Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2.  J Med Genet. 1996;  33 441-443
• 14 Caselitz M, Wagner S, Chavan A. et al . Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease).  Gut. 1998;  42 123-126
• 15 White R I Jr, Lynch-Nyhan A, Terry P. et al . Pulmonary arteriovenous malformations: Techniques and long-term outcome of embolotherapy.  Radiology. 1988;  169 663-669
• 16 Graf C, Perrett G, Torner J. Bleeding from cerebral arteriovenous malformations as part of their natural history.  J Neurosurg. 1983;  58 331-337
• 17 Kirchner J, Zipf A, Dietrich C F. et al . Universal organ involvement in Rendu-Osler-Weber disease: Interdisciplinary diagnosis and interventional therapy.  Z Gastroenterol. 1996;  34 747-752
• 18 Cloogman H M, DiCapo R D. Hereditary hemorrhagic telangiectasia: Sonographic findings in the liver.  Radiology. 1984;  150 521-522
• 19 Derauf B J, Hunter D W, Sirr S A. et al . Peripheral embolization of diffuse hepatic arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia.  Cardiovasc Intervent Radiol. 1987;  10 80-83
• 20 Gothlin J H, Nordgard K, Jonsson K, Nyman U. Hepatic telangiectasia in Osler’s disease treated with arterial embolization. Report of 2 cases.  Eur J Radiol. 1982;  2 27-30
• 21 Michaeli D, Ben-Bassat I, Miller H I, Deutsch V. Hepatic telangiectases and portosystemic encephalopathy in Osler-Weber- Rendu disease.  Gastroenterology. 1968;  54 929-932
• 22 Reilly P J, Nostrant T T. Clinical manifestations of hereditary hemorrhagic telangiectasia.  Am J Gastroenterol. 1984;  79 363-367
• 23 Christian H A. Osler: Recollections of an undergraduate medical student at Johns Hopkins.  Arch Intern Med. 1949;  84 77-83
• 24 Martini G A. The liver in hereditary haemorrhagic teleangiectasia: An inborn error of vascular structure with multiple manifestations: A reappraisal.  Gut. 1978;  19 531-537
• 25 Ballauff A, Koletzko S. Hereditary hemorrhagic telangiectasia with juvenile polyposis - coincidence or linked autosomal dominant inheritance?.  Z Gastroenterol. 1999;  37 385-388
• 26 Kolarz G, Pietschman H. Osler’s disease. Clinical results of 24 cases with special reference to liver findings.  Wien Z Inn Med. 1972;  53 17-25
• 27 Sackier J M, Dawson P, Allison D, Spencer J. An unusual angiogram in a patient with gastrointestinal bleeding.  Clin Radiol. 1990;  41 425-426
• 28 Blobe G C, Schiemann W P, Lodish H F. Role of transforming growth factor beta in human disease.  N Engl J Med. 2000;  342 1350-1358
• 29 Daly J J, Schiller A L. The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).  Am J Med. 1976;  60 723-726
• 30 Bjoro K, Schrumpf E, Elgjo K, Kolmanskog F. Monstrous ascites in hereditary haemorrhagic telangiectasia.  Scand J Gastroenterol. 1995;  30 92-24
• 31 Caselitz M. Morbus Osler. Gebel M. Gastroenterologische und hepatologische Sonographie Berlin, Blackwell; 1999,: 50-51
• 32 Weik C, Johanns W, Janssen J, Greiner L. The liver and hereditary hemorrhagic telangiectasia.  Z Gastroenterol. 2000;  38 31-37
• 33 Buscarini E, Buscarini L, Civardi G. et al . Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Imaging findings.  Am J Roentgenol. 1994;  163 1105-1110
• 34 Ouchi K, Matsubara S, Mikuni J. et al . The radiologic presentation of Osler-Weber-Rendu disease of the liver.  Am J Gastroenterol. 1994;  89 425-428
• 35 Varma D G, Schoenberger S G, Kumra A, Agrawal N, Robinson A E. Osler-Weber-Rendu disease: MR findings in the liver.  J Comput Assist Tomogr. 1989;  13 134-135
• 36 Chavan A, Galanski M, Wagner S. et al . Hereditary hemorrhagic telangiectasia: Effective protocol for embolization of hepatic vascular malformations -experience in five patients.  Radiology. 1998;  209 735-739
• 37 Allison D J, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: A review of 75 procedures.  Lancet. 1985;  1 595-599
• 38 Brohee D, Franken P, Fievez M. et al . High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment.  Arch Intern Med. 1984;  144 1282-1284
• 39 Roman C F, Cha S D, Incarvito J, Cope C, Maranhao V. Transcatheter embolization of hepatic arteriovenous fistula in Osler- Weber-Rendu disease - a case report.  Angiology. 1987;  38 484-488
• 40 Whiting J HJ, Morton K A, Datz F L, Patch G G, Miller F JJ. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: Case report.  J Nucl Med. 1992;  33 260-262
• 41 Odorico J S, Hakim M N, Becker Y T. et al . Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia.  Liver Transpl Surg. 1998;  4 483-490
• 42 Trotter J F, Suhocki P V, Lina J R. et al . Hereditary hemorrhagic telangiectasia causing high output cardiac failure: Treatment with transcatheter embolization.  Am J Gastroenterol. 1998;  93 156-171
• 43 Jackson J E. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Treatment with embolization (letter).  Radiology. 1999;  213 927-928
• 44 Stockx L, Raat H, Caerts B. et al . Transcatheter embolization of hepatic arteriovenous fistulas in Rendu- Osler-Weber disease: A case report and review of the literature.  Eur J Radiol. 1999;  9 1434-1437
• 45 Zentler-Munro P L, Howard E R, Karani J, Williams R. Variceal haemorrhage in hereditary haemorrhagic telangiectasia.  Gut. 1989;  30 1293-1297
• 46 Bourgeois N, Delcour C, Deviere J. et al . Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure.  J Clin Gastroenterol. 1990;  12 236-238
• 47 Miller F JJ, Whiting J H, Korzenik J R, White R I. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia (letter).  Radiology. 1999;  213 928-930
• 48 Radtke W E, Smith H C, Fulton R E, Adson M A. Misdiagnosis of atrial septal defect in patients with hereditary telangiectasia (Osler-Weber-Rendu disease) and hepatic arteriovenous fistulas.  Am Heart J. 1978;  95 235-242
• 49 Neumann U P, Knoop M, Langrehr J M. et al . Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation.  Transpl Int. 1998;  11 323-326
• 50 Zieren J, Buttemeyer R, Muller J M. Adjustable „banding” of the hepatic artery in treatment of shunt-induced heart failure in Osler-Rendu-Weber disease.  Chirurg. 1998;  69 639-641
• 51 Boillot O, Bianco F, Viale J P. et al . Liver transplantation resolves the hyperdynmic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement.  Gastroenterology. 1999;  116 187-192
• 52 Bauer T, Britton P, Lomas D. et al . Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia.  J Hepatol. 1995;  22 586-590
• 53 Mendoza A, Oliff S, Elias E. Hereditary haemorrhagic telangiectasia and secondary biliary cirrhosis.  Eur J Gastroenterol Hepatol. 1995;  7 999-1002
• 54 Saxena R, Hytiroglou P, Atillasoy E O. et al . Coexistence of hereditary hemorrhagic telangiectasia and fibropolycystic liver disease.  Am J Surg Pathol. 1998;  22 368-372

Anschrift für die Verfasser